Molecular Biometrics Snags $12M For IVF Procedure
Luke Timmerman11/10/08
Molecular Biometrics has raised $12 million in a Series A round of venture capital from Boston-based Oxford Bioscience Partners and Safeguard Scientifics. The cash will be used to support development of ViaMetrics, a diagnostic tool to help doctors identify which embryos created through in vitro fertilization have the greatest chance to become viable embryos. The company is currently headquartered in Chester, NJ, although it plans to move to the Boston area in early 2009.
Luke Timmerman is the National Biotech Editor of Xconomy, and the Editor of Xconomy Seattle. E-mail him at ltimmerman@xconomy.com or follow him on Twitter at twitter.com/ldtimmerman.
